CD8A and colorectal carcinoma: Interestingly, in our study, CD8+ T cells did not emerge as a cell type significantly associated with 5-year survival in CRC patients in the TCGA cohort, irrespective of stage (Figure 5), in all 3 platforms (CIBERSORT, xCell and MCP-counter).